1. Home
  2. DXCM vs CG Comparison

DXCM vs CG Comparison

Compare DXCM & CG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DexCom Inc.

DXCM

DexCom Inc.

HOLD

Current Price

$58.89

Market Cap

26.5B

Sector

Health Care

ML Signal

HOLD

Logo The Carlyle Group Inc.

CG

The Carlyle Group Inc.

HOLD

Current Price

$49.64

Market Cap

21.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXCM
CG
Founded
1999
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
26.5B
21.2B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
DXCM
CG
Price
$58.89
$49.64
Analyst Decision
Strong Buy
Buy
Analyst Count
21
14
Target Price
$85.33
$66.43
AVG Volume (30 Days)
4.5M
3.2M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
2.93%
EPS Growth
47.18
N/A
EPS
0.51
N/A
Revenue
N/A
N/A
Revenue This Year
$14.46
$16.70
Revenue Next Year
$12.31
$16.17
P/E Ratio
$118.88
$25.18
Revenue Growth
N/A
N/A
52 Week Low
$54.11
$43.19
52 Week High
$89.07
$69.85

Technical Indicators

Market Signals
Indicator
DXCM
CG
Relative Strength Index (RSI) 39.27 50.16
Support Level $56.72 $45.59
Resistance Level $60.85 $54.62
Average True Range (ATR) 2.07 2.24
MACD 0.06 0.03
Stochastic Oscillator 28.53 47.55

Price Performance

Historical Comparison
DXCM
CG

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

About CG The Carlyle Group Inc.

Carlyle Group is one of the world's largest alternative-asset managers, with $474.1 billion in total AUM, including $332.0 billion in fee-earning AUM, at the end of September 2025. The company has three core business segments: global private equity, which includes its private equity, real estate, infrastructure, and natural resources offerings (with $163.5 billion in total AUM and $101.1 billion in fee-earning AUM), global credit ($208.5 billion/$167.2 billion), and investment/fund solutions, known as Carlyle AlphInvest ($102.1 billion/$63.7 billion). The firm primarily serves institutional investors and high-net-worth individuals. Carlyle operates through 29 offices across five continents, serving more than 3,100 active carry fund investors from 87 countries.

Share on Social Networks: